Menu
Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10
Original Research
Cost-consequence model comparing eltrombopag versus romiplostim for adult patients with chronic immune thrombocytopenia
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 8,829 | Dovepress* | 7,602+ | 1,120 | 8,722 | |
| PubMed Central* | 1,227 | 286 | 1,513 | ||
| Totals | 8,829 | 1,406 | 10,235 | ||
| *Since 1 November 2018 | |||||
View citations on PubMed Central and Google Scholar